QT
AXDX

Quantbot Technologies’s Accelerate Diagnostics AXDX Stock Holding History

Quantbot Technologies’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13
Closed -$1K – 1450
2021
Q1 		$1K Sell
13
-753
-98% -$76.4K ﹤0.01% 1343
2020
Q4 		$58K Buy
766
+666
+666% +$59.6K 0.01% 834
2020
Q3 		$10K Buy
100
+65
+186% +$9.02K ﹤0.01% 1112
2020
Q2 		$5K Buy
+35
New +$3.45K ﹤0.01% 1004
2018
Q2 		– Sell
-56
Closed -$12K – 1190
2018
Q1 		$12K Buy
+56
New +$14.7K ﹤0.01% 1103
2017
Q4 		– Sell
-104
Closed -$23K – 1185
2017
Q3 		$23K Sell
104
-730
-88% -$179K ﹤0.01% 1045
2017
Q2 		$228K Buy
+834
New +$226K 0.02% 636
2016
Q4 		– Sell
-198
Closed -$54K – 1055
2016
Q3 		$54K Buy
+198
New +$43.8K 0.01% 840

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's AXDX Position: Q2 2021 in Review

Quantbot Technologies sold out of Accelerate Diagnostics (AXDX) in Q2 2021, closing a stake of 13 shares — an estimated $1K sold.

Quantbot Technologies first reported a position in AXDX in Q3 2016 and held it in 8 quarters. The position peaked at $228K in Q2 2017. 95 funds tracked by Wall St. Rank hold AXDX as of Q2 2021.

  • Quantbot Technologies reported no remaining Accelerate Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Quantbot Technologies sold 13 Accelerate Diagnostics shares in Q2 2021, an estimated $1K.
  • Quantbot Technologies first reported a position in Accelerate Diagnostics in Q3 2016 and held it in 8 quarters.
  • Quantbot Technologies's Accelerate Diagnostics position peaked at $228K in Q2 2017.
  • 95 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2021.

Based on Quantbot Technologies's 13F filing for Q2 2021, filed 12 Aug 2021.